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1154-81 Relations of Left Ventricular Hypertrophy to Markers of 
Systemic Inflammation and Microangiopathy in Adults 
With Type II Diabetes: The Strong Heart Study 
Vittodo Palmied. Russell P. Tracy, Mary J, Roman, Lyle Best, Aldo Celentano, Giovanni 
de Simone, David C. Robbins, Richard B. Fabsitz, Barbara V. Howard, Richard B. 
Devereux, Weill Medical College of Cornell Universi~ New York, New York. 
Background: Left ventricular (LV) hypertrophy (H) is a marker of preclinical cardiovascu- 
lar disease (CVD) associated with elevated fibrinogen and microangiopathy. In adults 
with diabetes but without clinical CVD, we evaluated whether relations of LV mass (M) to 
fibrinogen and CRP were explained by microangiopathy. 
Methods: We selected 1,414 American Indian adults with diabetes (WHO cdteria; 60+7 
yrs/old, 52% with hypertension (HTN)] without clinically overt CVD, LVM index >49.2 g/ 
m 2'7 in men or >46,7 gJm 2"7 in women defined LVH. Urinary albumin/creatinine (UACR) 
_>30 mg/g defined microangiopathy. 
Results: LVH (n=422) was associated with higher levels of fibrinogen (410 vs 371 mg/ 
dl), CRP (9.44 vs 6.88 mg,'L) and UCRA (1,412 vs 456 mg,'g, all p<0.01). In a multiple 
regression analysis adjusted for gender, body mass index (BMI), systolic blood pressure 
(SBP), HTN, Doppler stroke volume (SV) and microangiopathy, LVM index was associ- 
ated with fibrinogen (~=0.08, p<0.01), but not with CRP (multiple R=0.52, p<0.001); CRP 
was related to LVM index (~=0.07, p<0.01)only when both fibdnogen and albuminuria 
status were excluded from the set of covadates (multiple R--0.5O, p<0.001 ).After control- 
ling for age, gender, SBP and HTN, tog-UACR was more closely related to fibrinogen 
(partial r=0.47, p<0.001) than to CRP (partial r=0.05, p=NS). BMI was related to both 
fibrinogen (partial r=0.13) and CRP (partial r=0.23, both p<0.Ol), independent of age, 
gender, SBP, HTN and Log-UACR. 
Concluelons: In a population-based cohort of adults with diabetes, but without clinical 
CVD, fibrinogen was higher with LVH independently of microangiopathy. The association 
of LVH to higher fibrinogen and microangiopathy obscured the univadate association 
between LVH and CRP. Higher fibdnogen in the presence of LVH suggests higher blood 
viscosity and prothrombotic tendency associated with increased LVM. Fibrinogen was 
more closely related to albuminuda than CRP. Obesity, a strong stimulus to LVH and 
source of proinflammatory cytokines, was independently associated with both fibrinogen 
and CRP. 
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853-2 Role of Circulating Myeloperoxidase Positive 
Monocytes and Neutrophils In Occlusive Coronary 
Thrombi 
Allen P. Burke. Frank D. Kolodgie, Andrew Farb, Deena Weber, Renu Virmani, Armed 
Forces Institute of Pathology, Washington, Dist. of Columbia. 
Background: Although the procoagulant potential of activated monocytes is well 
described, the association between inflammation and thrombus propagation has not 
been investigated. 
Methods: Coronary arteries with acute luminal thrombi were studied in longitudinally ori- 
ented histologic sections 2.5 cm in length. Morphometdc analysis of thrombus length, 
degree of occlusion and length of the necrotic core were performed. Thrombi were char- 
acterized using antibodies directed against fibrin if and CD61-platelet antigen. Total (vac- 
uolated and non-vacuolated) macrophages were identified by anti-CD68, neutrophils and 
non-vacuolated macrophages by anti-myeloperoxidase (MPO), and neutrophils by anti- 
CD66. 
Results: in 82% of thrombi platelet density was greater at the site of plaque disruption 
while fibrin comprised a larger percentage of the propagated thrombus. Occlusive 
thrombi were longer (8.3 ± 4.2 mm) than non-occlusive thrombi (2.9 ± 2.4 ram, p=.01). 
There was no difference in underlying diameter luminal narrowing (71 ± 11% vs. 71 ± 
20%, respectively) or length of necrotic core (8.9 ± 5.1 vs. 9.3 ± 6.6, respectively). Within 
the clot, occlusive thrombi showed a greater mean density than non-occlusive thrombi of 
CD68-positive macrophages (15.7 ± 12.5% vs. 3.0 ± 2.7%, p=0.05), MPO+ cells (12.2 ± 
7.5% vs. 5 ± 2.7%, p=.006), and neutrophils (2.9 ± 3.4 vs. 0.36 ± 0.50%, p=.03). Like- 
wise, the length of the thrombus showed a positive correlation with the intra-clot density 
of CD68-positive macrophages (p=0.004) and MPO-positive cells (p=O.04). In the dis- 
rupted fibrous cap, the density of MPO+ cells was greater in occlusive {5.5%) vs. non- 
occlusive thrombi (0.9%); this association was similar for neutrophUs (0.7% vs. 0.4%), 
but not for total CD68+ macrophages (13% vs. 20%, respectively). 
Conclusion: Platalet-rich occlusive thrombi are associated with greater density of mac- 
rophages and MPO+ cells in the thrombus, and to a lesser degree MPO+ cells in the dis- 
rupted cap. Proinflammatory mediators within the thrombus and tissue factor dedved 
from MPO+ cells may contribute to occlusive thrombL 
11:00 a.m. 
853-3 Monocyte-Endothelial  Cell Interaction Inhibits 
Endothelial Cell Apoptosis 
Shiaemasa Hashimoto, Hiroto Ueba, Masatoshi Kuroki, Yasuhiro Maejima, Aoi Nabata, 
Naoko Ikeda, Nobuhiko Kobayashi, Takanod Yasu, Muneyasu Saito, Masanobu 
Kawakami, Jichi Medical School Omiya Medical Center, Saitama, Japan. 
Backgroud: Monocyte-endothelial cell (EC) interaction stimulates production of growth 
factors in EC and may be involved in EC survival. Recent work suggested that monocyte 
adhesion to EC activates signal transduction events necessary for EC survival, However, 
the effect of monocyte-EC interaction on EC apoptosis is unclear. In the present study we 
used human monocyte-dedved cell line (THP-1) and human umbilical vein endothelial 
cells (HUVEC) to investigate the effect of monocyte-EC interaction on apoptosis of 
HUVEC. Method and Results: THP-1 were stimulated with phorbol 12-myristate 13- 
acetate to adhere to HUVEC and HUVEC were cultured in serum-free medium for 12 h 
with or without THP-1. Apoptosis of HUVEC was examined by morphological findings 
and caspase-3 activity assay. Production of Bcl-2 and Bax was evaluated by Western 
blot. Caspase-3 activity of HUVEC co-cultured with THP-1 was significantly inhibited 
compared to HUVEC without THP-1 (60% inhibition, n=5; p<0.05). Fluorescence micro- 
scopical findings of apoptosis were also inhibited in HUVEC with THP-1 , using FITC- 
conjugated permeable caspase inhibitor VAD-FMK. Production of Bcl-2 increased 
2.3±0.4-fold in HUVEC with THP-1 compared to HUVEC without THP-1 (n=5; p<0.05), 
whereas Bax production was unchanged. However these findings were not shown in 
HUVEC cultured in conditioned-medium derived from direct cocoiture nor in separated 
coculture. Western blot anakysis disclosed that ERK1/2 and p38 MAPK were phosphory- 
lated in HUVEC with THP-1, however, a MEK inhibitor PD98059 and a p38 MAPK inhibi- 
tor SB203580 had no effect on caspase-3 activity in HUVEC with or without THP-I. To 
investigate of molecular mechanism of apotosis inhibition, we also assessed other path- 
way but revealed no effect of Src inhibitor ppl, PI3-kinase inhibitor LY294002, PKC inhib- 
itor Staurosporine and Calphostin C , and NOS inhibitor LNAME.Conclua|on: These 
data demonstrate that THP-1-HUVEC direct contact inhibits apoptosis of HUVEC and 
Bcl-2 may be involved in a signaling pathway necessary for EC survival mediated b~, 
monocyte-EC interaction. Further examinations are needed to reveal mechanism of this 
novel role of cell-to-cell interaction. 
11:15 a.m. 
853-4 Monocyte- lnduced Kil l ing of Vascular Smooth Muscle 
Cells: Is M-CSF the Final Common Pathway? 
Saniav S. Vasudevan. Puvi N.'Seshiah, Dean Kereiakes, Pascal J. Goldschmidt- 
Clermont, Duke University Medical Center, Durham, North Carolina. 
Background: Macrophage Colony Stimulating Factor (M-CSF) is an important hemato- 
poietic growth factor for the survival and proliferation of macrophages. A higher concen- 
tration of M-CBF has been associated with poor outcome in patients with coronary artery 
disease. We have shown that M-CSF is needed to reconstitute the killing of vascular 
smooth muscle cell (VSMC) by monocyta-derived macrophages, as is observed in vul- 
nerable plaques. We have now hypothesized that the effect of M-CSF in promoting the 
apoptosis of VSMC, upon interacting with macrophages, is specific. 
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853-1 Plaque Inflammation in AtheroscleroUc Rabbits Can Be 
Identified By SPIO; Introducing a Noninvasive Method 
for Imaging Macrophage Infi ltration in Active and 
Inflamed Vulnerable Plaque 
Maziar Azadpour, Silvio Litovsky, Alireza Zarrabi, Ward Casscells, James Willerson, 
Morteza Naahavi. Center for Vulnerable Plaque Research, University of Texas-Houston 
and Texas Heart Institute, Houston, Texas. 
Background: Super para magnetic iron oxide (SPIO) nanoparticles are magnetic reso- 
nance imaging contrast agents with a central core of iron oxide coated by polysaccha- 
rides which are currently used for MRI detection of metastatic ancer. After intravenous 
(IV) injection, these particles are avidly enguffed by circulating monocytes and tissue 
macrophages, SPIO creates significant darkening in MR images mainly due to its 1"-2 
shortening effect, Accumulation of SPIO loaded macrophages in inflammatory foci 
enables imaging of inflammation by MRI. 
Previously we have shown accumulation of SPIO loaded macrophages in aortic plaques 
of Apo E deficient mice. Here we report similar finding with slightly different features in 
atheroscierotic plaques of hereditary hypercholestrolemic Watanabe rabbits. 
Methods: Three hereditary hypercholestrolemic Watanabe rabbits (>36 months) were 
injected IV lmmol/kg SPIO. Then the animals were sacrificed st days 5 and 10 after 
injection. Multiple samples from aortic root to abdominal aorta, as well as heart, lung, kid- 
neys, liver and spleen were taken and stained with H&E, Iron and rabbit anti macrophage 
antibody (RAM t I ). 
Results: SPIO particles were abundantly found in macrophages in reticuloendothelial 
system, liver, spleen and lungs. In the aorta, the presence of SPIO was mostly restricted 
to macrophages and foam ce~ls in the sub-endothelial areas of the atherosclerotic 
plaques suggesting only newly recruited macrophages. No difference in the distribution 
pattern was detected between days 5 and 10. Areas of plaque hemorrhage were minimal 
in these animals.. The cap ovedying the macrophages was always thin. Iron-laden mono- 
cytes were also seen in the lumen, suggesting a relatively easy transport across the ves- 
sel endothelium. 
Conclusion: 1) The SPIO nano-particles offer a unique and physiologic opportunity to 
trace macrophage infiltration into atherosclerotic plaque. 2) SPIO can be imaged non- 
invasively by MRI enabling detection of plaque inflammation, a well-known feature of vul- 
nerable plaques. 3) Since SPIO is clinically available, human clinical trials are feasible 
and greatly warranted. 
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Methods: VSMC grown in serum free media for 48hours were co-cultured with mono- 
cytes (M) for 72hours, in the presence of M-CSF or ILI~. The apoptotic index was mea- 
sured using an established apoptosis assay. M-CSF and ILI~ were used at 
concentrations of t00ng/ml and 100pg/ml to lng,'ml, respectively. Apprepriate controls 
were set up for all experiments. 
Resulte: ILl~ at physiological concentrations (100pg/ml) did not increase VSMC apopto- 
sis (10.5±2.4%); this was similar to control VSMC with M alone, whereas M-CSF-acti- 
vated M significantly increased VSMC apoptosis (60.0+-3.0%, p< 0.008). 
Suprephysiological doses of ILI~ (500pg and lng/ml) did cause an increase in mono- 
cyte-induced killing of VSMC (59.5+ 3.5% and 59.0-J: 3.8% respectively). However, such 
effect was shown to be mediated by endogenous production of M-CSF upon ILI~ stimu- 
lation. Thus, VSMC co-cultured with M and tL113 (500pg and 1 ng/ml) were pretreated with 
an anti M-CSF neutralizing antibody (lp.g/ml). The VSMC apoptosis was nearly abro- 
gated in the presence of the anti M-CSF mAb (17.0± 2.1% and 13.6±1.9%, p_<0.007 and 
p_<0.005 respectively), when compared to VSMC co-cultured with M-CSF activated M 
alone. A nonspecific isotype control (IgG2a) was used and did not block the ILl (lng/ml) 
induced VSMC apoptosis (55.0±2.0%). Conclusions; M-CSF could function as an 
important rate limiting eytokine in the process of activated monocyte induced killing of 
VSMC, suggesting a final common pathway for atheroma plaque destabUization. 
11:30 a.m. 
853-5 Arterial Injury in ApoE -/- and C57/BL6 Wild Type Mice: 
Evidence for Macrophage Apoptosis as a Mechanism 
Regulating Tissue-Factor Expression and Plaque 
Growth 
Randolph Hutter. Juan J. Badimon, Bernhard V. Sauter, John T. Fallon, Valentin Fuster, 
Cardiovascular Institute. Mount Sinai Medica/ Center, New York, New York. 
Background: Macrophages undergoing apoptosis are considered contributing to pro- 
gression of athereoscleretic lesions. Tissue factor is a key cell-mediated activator of extrin- 
sic coagulation-cascede and can induce thrombus formation. 
Methods: In the present study, we examined the role of macrophage apoptosis on 
plaque growth by comparing neointima formation in ApoE -/- (n=10) and C57/BL 6 wild 
type mice (n=23) in a model of femoral arterial denudation injury. 
Results: Arterial injury resulted in significantly increased neointima formation in ApoE -/- 
mice at 4 weeks compared to wild type mice (4.84 ± 1.26 mm 2 x 10 .2 vs. 0.73 ± 0.03 
mm 2 x 10"2; P<0.01). Apoptotic macrophages and foam cells as detected by cespase*3 
expression, characteristic morphology and positive staining for MOMA-2 were found only 
in lesions of ApoE -/- mice and accounted for up to 33 ± 6 % of intimal cells at 4 weeks 
after arterial injury compared to less than 0.5 % apoptotic ells in neointima of wild type 
mice (P<0.01). Importantly, neointima size significanly correlated with the content of apo- 
ptotic macrophages in neointima (r=0.64, P<0.01). In addition, apoptotic macrophages 
were directly associated with increased cellular tissue factor expression (r=0.97, P<0.01) 
as well as reduced alpha-actin expression (r=-0.75, P<O.01) in neointima of ApoE -/- 
mice. 
Conclusions: Apoptosis of maerophages and enhanced expression of cellular tissue 
factor in neointima correlated with increased plaque growth and change of neointima to 
an unstable plaque-like phenotype. These findings point to an important role of pro- 
grammed cell death occuring in macrophages in modulating arterial esion biology and 
controlling thrombogenie properties of intimal lesions following arterial injury. 
11:45 a.m. 
853-6 Asymmetric Dimethylarginine Stimulates the 
Expression of Matrix Metalloproteinase-9 in Human 
Monocytes via Tumor Necrosis Factor-a 
Euv-Mvouno Jeono. Sungyoul Hong, Jeong-Euy Park, Samsung Medica/Center, 
Sungkyunkwan University School of Medicine, Seoul, South Korea, Center for Clinical 
Research, Samsung Biomedical Research Institute, South Korea. 
Background: Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibi- 
tor of nitric oxide synthase, has recently been reported as an atherogenic molecule. 
ADMA induces the endothelial dysfunction and influences the monocyte adhesion to the 
endothelial cells. We tried to investigate whether ADMA induces the release of proinflem- 
matory cytokines and the expression of matrix metalloproteinase-9 (MMP-9), 
Methods: Human monocytic ell line, THP-1 was incubated with ADMA (0.1 - 10 pM) in 
a time-dependent manner and supernatants were harvested for the detection of proin- 
flammatory cytokines by ELISA. The expression of MMP-9 by ADMA was determined by 
gelatin-zymography and northern hybridization. 
Resulte: Tumor necrosis factor (TNF)-c~ was released at about 800 pg/ml within 12 h, 
whereas interleukin (IL)-6 was not. ADMA also stimulated the expression of monocytic 
chemotatic factors such as IL-8 and monocyte chemoattractant protein (MCP)-I. No 
effects were detected by symmetric dimethylarginine and N-monomethylarginine. ADMA 
induced the secretion of MMP-9 in a dose-dependent manner. To determine whether 
TNF-~ mediated MMP-9 up-regulation, anti-TNF-c( monoclonal antibodies were co-incu- 
bated with ADMA to block the action of TNF-~. Anti-TNF-~ monoclonal antibody blocked 
completely the induction of MMP-9 by ADMA. Conclusion: This study suggests that 
ADMA induces the release of proinflammatory c tokines, TNF-c~, IL-8 and MCP-1 in 
monocytes. The up-regulation of MMP-9 is mediated by TNF-c~ in ADMA treated mono- 
cytes. These findings provide the evidences that ADMA may be involved in the plaque 
formation and instabilization i atherosclerosis. 
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1176-69 Effects of Low Dose Hormone Replacement Therapy on 
Nitric Oxide BioacUvity and Markers of Inflammation 
Compared With Conventional Dose in Poetmenopauaal 
Women 
Kwano K. Koh. Mi-Seung Shin, Gachon Medical School, Incheon, South Korea. 
Background: We have previously shown that conventional dose hormone replacement 
therapy (C-HRT) improved nitric oxide (NO) bioactivity and reduced markers of inflam- 
mation in postmenopausal women (PMW). The effects of low-dose hormone replace- 
ment herapy (L-HRT) has not yet observed. 
Methods: We administered micronized progesterone (MP) 100 mg with conjugated 
equine estrogen (CEE) 0.025 (C-HRT) or 0.3 (L-HRT) mg daily for 2 months to 15 PMW 
with a washout period of 2 months in a randomized, double-blind, crossover study. Data= 
meani¾SD. *=P<0.01, **=P<0.001 vs. Baseline. 
Results: L-HRT and C-HRT significantly changed lipoprotein levels. L-HRT improved 
flow-mediated ilation (FMD) and tended to reduce plasma E-selectin, but not VCAM-1, 
CRP and fibrinogen levels compared with respective basetine levels. However, there 
were no significant differences between L-HRT and C-HRT regarding these effects. 
There were no significant correlations between absolute levels or pement changes of 
CRP levels and absolute levels or percent changes of FMD or E-selectin (all riA0.155). 
Conclusion: L-HRT has comparable ffects to C-HRT in PMW regarding lipoproteins, 
FMD, and markers of inflammation. 
Baseline1 C-HRT Baseline2 L-HRT 
FMD (%) 4 .80+1.26  7.14+1.75"* 4.93+1.23 6.40+-1.64"* 
E-selectin 41±9 37±10" 39~8 37+9 
VCAM-1 468±172 484±179 464+-175 442+168 
CRP 0.26_+0.21 0.30-~'0.31 0 .19±0.15  0.19-Z0.09 
1176-71 Cyclosporine-lnduced Hypertension and Vascular 
Superoxide Production 
Joseeh N. Graziano, Carolyn L. Buller, John R. Charpie, University of Michigan, Ann 
Arbor, Michigan. 
Background: Cyclospodne A (CSA)-induced endothelial dysfunction and systemic 
hypertension contribute to significant morbidity and mortality following orthotopic heart 
transplantation. Several experimental models of hypertension have recently been linked 
with endothelial dysfunction and increased vascular oxidant stress. We hypothesize that 
CSA increases vascular superoxide (02-) production leading to a decrease in bioavail- 
able nitric oxide, an endogenous vasodilator. 
Methods: Adult male C57BL/6J mice (age 8-10 weeks) were treated for 12 days with 
either CSA (25 mg/kg in olive oil via intrapedtoneal injection; n=12), vehicle (n=5), 1 mM 
Tempol (a superoxide dismutase mimetic administered in the drinking water; n=5) or CSA 
+ Tempol (n=5). Systolic blood pressure (SBP) was measured aily by tail cuff method. 
Additionally, cultured human umbilical vein endothelial cells (HUVEC) were grown to con- 
fiuecce and incubated in phosphate buffered saline with 0.1 pM CSA (or ethanol vehicle) 
for ten minutes. Superoxide production was measured (n=4) by lucigenin-dedved chemi- 
luminescence (5 p.M). 
Results: CSA administration resulted in a significant increase in SBP from 113+5 mmHg 
(mean ± SEM) pretreatment to 184±2 mmHg on day 12 (p<0.0001). In contrast, co- 
administration of Tempol with CSA completely inhibited the CSA-induced increase in 
SBP (111±2 mmHg on day 12). Neither vehicle nor Tempol alone had any effect on SBP. 
Incubation of HUVEC with CSA resulted in a 15+1% increase in 02- production com- 
pared to HUVEC alone (p=0.02). Incubation of HUVEC with the endothelial nitric oxide 
synthase inhibitor N~°-monomethyl L-arginine (L-NMMA, 1raM) resulted in an 11+_2% 
increase in 02" production (p=0.04). Furthermore, there was a synergistic response to L- 
NMMA and CSA with an 85+_10% increase in 02" production compared to HUVEC alone 
(p<0.001). Tempol (1raM) completely inhibited the increase in 02" in both CSA and CSA 
+ L-NMMA treated cells. 
Conclusions: CSA treatment increases blood pressure and endothelial cell 02" produc- 
tion. Inhibition of nitric oxide production augments the increase in CSA-induced 02" pro- 
duction, suggesting that excess 02" may scavenge nitric oxide and decrease its 
bioavailability. 
